biblio

Export 8 results:
Filters: Author is Das, Pronay  [Clear All Filters]
Journal Article
P. Das and D. Reddy, S., “Total synthesis of twelve membered resorcyclic acid lactones, (R)-penicimenolide A, (R)-resorcyclide and (R)-dihydroresorcyclide”, Tetrahedron, vol. 85, p. 132059, 2021.
P. Das, Babbar, P., Malhotra, N., Sharma, M., Jachak, G. R., Gonnade, R. G., Shanmugam, D., Harlos, K., Yogavel, M., Sharma, A., and D. Reddy, S., “Specific stereoisomeric conformations determine the drug potency of cladosporin scaffold against malarial parasite”, Journal of Medicinal Chemistry, vol. 61, no. 13, pp. 5664-5678, 2018.
P. Das, Mankad, Y., and D. Reddy, S., “Scalable synthesis of cladosporin”, Tetrahedron Letters, vol. 60, no. 12, pp. 831-833, 2019.
Y. Mankad, Thorat, S. S., Das, P., Krishna, G. Rama, Kontham, R., and D. Reddy, S., “Ready access to benzannulated [5,5]-oxaspirolactones using Au(III)-catalyzed cascade cyclizations”, Journal of Organic Chemistry, vol. 87, no. 5, pp. 3025-3041, 2022.
Y. Mankad, Das, P., Pathan, E., Deshpande, V. M., and D. Reddy, S., “Herbicidal bio-assay of isocladosporin enantiomers and determination of its plausible absolute configuration”, Journal of Antibiotics, vol. 74, no. 4, pp. 280-284, 2021.
G. Lauro, Das, P., Riccio, R., D. Reddy, S., and Bifulco, G., “DFT/NMR approach for the configuration assignment of groups of stereoisomers by the combination and comparison of experimental and predicted sets of data”, Journal of Organic Chemistry, vol. 85, no. 5, pp. 3297-3306, 2020.
P. Babbar, Das, P., Manickam, Y., Mankad, Y., Yadav, S., Parvez, S., Sharma, A., and Reddy, S., “Design, synthesis, and structural analysis of cladosporin-based inhibitors of malaria parasites”, ACS Infectious Diseases, vol. 7, no. 6, pp. 1777–1794, 2021.
R. Zhang, Noordam, L., Ou, X., Ma, B., Li, Y., Das, P., Shi, S., Liu, J., Wang, L., Li, P., Verstegen, M. M. A., D. Reddy, S., van Der Laan, L. J. W., Peppelenbosch, M. P., Kwekkeboom, J., Smits, R., and Pan, Q., “Biological process of lysine-tRNA charging is therapeutically targetable in liver cancer”, Liver International, vol. 41, no. 1, pp. 206-219, 2021.